Analysis of the Domain Specific Function of the Wiskott Aldrich Syndrome Protein, in Vitro and in Vivo

Total Page:16

File Type:pdf, Size:1020Kb

Analysis of the Domain Specific Function of the Wiskott Aldrich Syndrome Protein, in Vitro and in Vivo Analysis of the Domain Specific Function of the Wiskott Aldrich Syndrome Protein, in Vitro and in Vivo By Austen Jonathan Jacob Worth A thesis submitted for the degree of Doctor of Philosophy 2009 1 Abstract Wiskott Aldrich Syndrome (WAS) is an X-linked immunodeficiency characterised by low numbers of low volume platelets, eczema, severe immunodeficiency and increased susceptibility to malignant and autoimmune diseases. Wiskott Aldrich Syndrome protein (WASp), the product of the gene mutated in WAS is a multidomain cytosolic protein which acts by integrating downstream signals from cell surface receptor signalling cascades and transduces these signals into remodelling of the actin cytoskeleton. WASp is involved in cellular processes as diverse as cell polarisation, migration, phagocytosis and T cell synapse formation. Dendritic cell function and migration is known to be impaired in WAS. Specifically, dendritic cells lacking WASp in both mice and humans show an impaired ability to form transient actin rich adhesive structures called podosomes. In this thesis, I am presenting the characterisation of a panel of domain deletion WASp proteins and a series of point mutations which, in children give rise to a range of disease phenotypes. I have expressed these constructs as GST tagged proteins and developed a bead based in vitro assay to asses the protein activity. I have compared the ability of these mutants to bind key regulators of WASp function, WIP and Cdc42, using a variety of immunoprecipitation techniques. Finally I have expressed EGFP tagged WASp proteins in myeloid cell lines to assess expression and stability of these constructs and in WASp null murine dendritic cells to assess their ability reconstitute podosomes. Point mutations which cause WAS have slightly increased actin polymerisation activity compared to wild type WASp (WT) and have a normal affinity for Cdc42. Although they have a reduced affinity for WIP compared to WT, there is still significant association of WIP to mutant WASp in cells. These mutants have reduced stability and different patterns of phosphorylation compared to WT, when expressed in myeloid cells lines. The EVH1, Polyproline and VCA domains of WASp are all essential for optimal actin polymerisation activity, whereas the Basic domain and the point mutation H246D (which inhibits Cdc42 binding) could be deleted with no loss of molecular activity. The EVH1 domain is essential for WIP binding and the Basic domain is essential for Cdc42 binding. Deletion of the EVH1 domain resulted in protein which had greater stability than WT WASp, suggesting that residues within the EVH1 domain are essential for the physiological degradation of WASp. This work demonstrates that mutant WASp which causes WAS in patients has normal molecular activity, but the regulation of mutant WASp degradation is impaired in myeloid cells. Results from this project also suggest that Cdc42 is not essential for normal WASp functioning, but does appear to be essential for the phosphorylation of the Y291 residue, which is known to be critical for the regulation of WASp activity. Further work will aim to elucidate the functional (in vivo) significance of these findings. 2 Acknowledgements I would like to thank all the members of the Molecular Immunology Unit at the Institute of Child Health for their help and patience during my three years work in the lab. In particular Gerben Bouma, Mike Blundell, Dale Moulding and Joao Metelo have been a constant source of advice, help, learning and encouragement, and Sue Ballard’s continual practical assistance has been invaluable. I would like to thank my collaborators for their help and useful discussion of my results. This includes Gareth Jones, Yolanda Calle, David Adamovich, Scott Snapper and particularly Giles Cory, who gave me an invaluable grounding at the start of my project. I would also like to acknowledge several colleagues from other laboratories who have kindly provided me with reagents or protocols. These include Ines Anton, Marc Krishner, Narayanaswamy Ramesh, Ritu Garg and Anne Ridley. I must give particular thanks to my supervisors Siobhan Burns and Adrian Thrasher, and to Christine Kinnon, head of the Molecular Immunology Unit, for their scientific, academic and professional help and advice. Siobhan in particular, has been a fantastic support, providing exemplary supervision to a difficult and single minded student. Finally I would like to thank my family, particularly Perys Worth, for their love and support during a difficult time completing this project. My greatest thanks, however, must be reserved for my wife, Louise, and son, Jonathan, without whose unerring love and support none of this would have been possible. Declaration All the work presented in this thesis is entirely my own with the following exceptions; (1) The Y291E and I294T WASp constructs were generated by Giles Cory and were a gift to me. (2) Cell sorting of U937 cells into high and low expressing cells was performed by Joao Metalo. (3) The counting of podosomes for figure 9.1e was performed by Joao Metelo and Siobhan Burns. One of the two DC preparations for this data was performed by myself, the other by Joao Metelo. 3 Publications Blundell,M.P., Bouma,G., Metelo,J., Worth,A., Calle,Y., Cowell,L.A., Westerberg,L.S., Moulding,D.A., Mirando,S., Kinnon,C., Cory,G.O., Jones,G.E., Snapper,S.B., Burns,S.O., and Thrasher,A.J. (2009). Phosphorylation of WASp is a key regulator of activity and stability in vivo. Proc. Natl. Acad. Sci. U. S. A 106, 15738-15743. Adamovich,D.A., Nakamura,F., Worth,A., Burns,S., Thrasher,A.J., Hartwig,J.H., and Snapper,S.B. (2009). Activating mutations of N-WASP alter Shigella pathogenesis. Biochem. Biophys. Res. Commun. 384, 284-289. Ancliff,P.J., Blundell,M.P., Cory,G.O., Calle,Y., Worth,A., Kempski,H., Burns,S., Jones,G.E., Sinclair,J., Kinnon,C., Hann,I.M., Gale,R.E., Linch,D.C., and Thrasher,A.J. (2006). Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 108, 2182-2189. Chou,H.C., Anton,I.M., Holt,M.R., Curcio,C., Lanzardo,S., Worth,A., Burns,S., Thrasher,A.J., Jones,G.E., and Calle,Y. (2006). WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cells. Curr. Biol. 16, 2337-2344. Frontpiece Acknowledgement Image of the tertiary structure of the interaction between WIP and the EVH1 do- main of NWASp. Reproduced with kind permision of the authors from Volkman et al., 2002 4 Contents 1 Introduction 22 2 Materials and Methods 88 3 Molecular Cloning, Protein Expression and Purification 122 4 Optimisation of Actin Polymerisation Assay 144 5 In vitro Actin Polymerisation Activity 179 6 Effect of WIP on WASp function in vitro 201 7 Effect of Cdc42 and assessment of phosphorylation on 225 WASp activation in vitro 8 EGFP-WASp expression in U937 cells 239 9 Discussion 269 Appendicies 285 References 298 5 Detailed Contents Detailed contents Frontpiece 1 Abstract 2 Acknowledgements 3 Declaration 3 Publications 4 Contents (summary) 5 Detailed contents 6 Figures 13 Tables 17 Abbreviations 18 1 Introduction 22 1.1 Clinical syndrome 22 1.1.1 Wiskott Aldrich Syndrome 22 1.1.1.1 Actin cytoskeleton in a normal immune response 23 1.1.1.2 T cell defects 25 1.1.1.3 B cell defects 26 1.1.1.4 Innate Immunity defects 27 1.1.1.5 Dendritic cell defects 28 1.1.1.6 Platelets 29 1.1.1.7 Eczema 29 1.1.1.8 Autoimmunity 29 1.1.1.9 Malignancy 30 1.1.1.10 Mouse model of Wiskott Aldrich Syndrome 30 1.1.2 X-linked Thrombocytopenia 31 1.1.3 X-linked Neutropenia 32 1.2 Genetics of WAS 33 1.2.1 WASp gene mutations 33 1.2.2 Genotype – Phenotype correlations 33 1.3 WASp family proteins 36 1.3.1 Evolution of WASp family proteins 38 1.3.2 NWASp 38 1.3.3 WAVE / SCAR proteins 38 1.4 Molecular structure of WASp 39 1.4.1 EVH1 domain 40 1.4.1.1 Proteins with homologous domains 40 1.4.1.2 Interaction with WIP and crystal structure 41 1.4.1.3 PIP2 binding 42 1.4.1.4 Src family kinase binding 42 1.4.1.5 Arp 2/3 binding and EVH1 contribution to WASp activation 42 6 Detailed Contents 1.4.1.6 Deletion of the EVH1 domain 44 1.4.2 Basic domain 44 1.4.2.1 Phospholipid binding 44 1.4.2.2 Deletion of the Basic domain 45 1.4.3 GBD and CRIB 45 1.4.3.1 Deletion of the GBD 46 1.4.4 Polyproline domain 46 1.4.4.1 Deletion of the Polyproline domain 46 1.4.5 VCA domain 48 1.4.6 Autoinhibition and Crystal structure 49 1.4.6.1 VCA – GBD autoinhibitory pseudo-domain 49 1.4.6.2 Other autoinhibitory interaction 50 1.4.6.3 Autoinhibitory conformation in vivo 50 1.4.6.4 XLN point mutations and WASp phosphorylation in GBD 51 1.5 WASp activation 51 1.5.1 Cdc-42 51 1.5.1.1 Rho Family GTPases 51 1.5.1.2 GEFs, GAPs and GDIs 53 1.5.1.3 Specificity of the Cdc-42 – WASp interaction 55 1.5.2 PIP2 56 1.5.2.1 Phosphatidylinositides in membrane dynamics 56 1.5.2.2 Cooperation with monomeric GTPases 56 1.5.2.3 Phosphatidylinositide interaction with the cytoskeleton 57 1.5.2.4 PIP2 binding to WASp 57 1.5.3 WASp activation by Cdc-42, PIP2 and TOCA 58 1.5.3.1 Experimental systems 58 1.5.3.2 Evidence of Cdc-42 induced activation 59 1.5.3.3 Crystal structure of Cdc-42 bound to WASp GBD 60 1.5.3.4 Activation of full length WASp 60 1.5.3.5 Synergistic activation by Cdc-42 and PIP2 61 1.5.3.6 TOCA1 62 1.5.3.7 Prenylation of Cdc-42 62 1.5.4 Cdc-42 independent WASp activation 63 1.5.5 Protein kinase binding and WASp phosphorylation 64 1.5.5.1 Tyrosine kinases 64 1.5.5.2 Phosphorylation of WASp 64 1.5.5.3 Role in WASp activation 66 1.5.6 SH3 domain containing proteins 67 1.5.6.1 SH3
Recommended publications
  • (Gefs & Gaps) of the Rho Family
    Structural and biochemical investigation of the activity, specificity and regulation of regulators (GEFs & GAPs) of the Rho family Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Mamta Jaiswal aus Indien Düsseldorf, November 2012 Aus dem Institut für Biochemie und Molekularbiologie II der Heinrich-Heine-Universität Düsseldorf Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: PD. Dr. Reza Ahmadian Koreferent: Prof. Dr. Dieter Willbold Tag der mündlichen Prüfung: 23.01.2013 Eidesstattliche Erklärung Hiermit erkläre ich an Eides statt, dass ich die hier vorgelegte Dissertation eigenständig und ohne unerlaubte Hilfe angefertigt habe. Es wurden keinerlei andere Quellen und Hilfsmittel, außer den angegebenen, benutzt. Zitate aus anderen Arbeiten wurden kenntlich gemacht. Diese Dissertation wurde in der vorgelegten oder einer ähnlichen Form noch bei keiner anderen Institution eingereicht und es wurden bisher keine erfolglosen Promotionsversuche von mir unternommen. Düsseldorf, im November 2012 To my family Table of Contents Table of Contents TABLE OF CONTENTS .................................................................................................. I TABLE OF FIGURES .................................................................................................... III PUBLICATIONS ...........................................................................................................
    [Show full text]
  • University of Cincinnati
    UNIVERSITY OF CINCINNATI Date: 1-Oct-2010 I, Jason Matthew Puglise , hereby submit this original work as part of the requirements for the degree of: Doctor of Philosophy in Cell & Molecular Biology It is entitled: Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells Student Signature: Jason Matthew Puglise This work and its defense approved by: Committee Chair: Robert Brackenbury, PhD Robert Brackenbury, PhD 11/1/2010 1,117 Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate Program of Cancer and Cell Biology of the College of Medicine by Jason M. Puglise M.Sc., Wright State University 2005 Committee Chair: Robert Brackenbury, Ph.D. ii ABSTRACT Puglise, Jason M. Ph.D., Cancer and Cell Biology Program. University of Cincinnati, 2010. Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells. The p21-activated kinase 1 (Pak1) is a putative Rac/Cdc42 effector molecule and a multifunctional enzyme implicated in a wide range of cellular and biological activities. Although well-established as a regulator of cytoskeletal and microtubule dynamics, Pak1 influences centrosome behavior and plays a part in the cell cycle. We examine the role Pak1 and its binding partner Pak1-interacting exchange factor (PIX) play in centrosome dynamics and in cell cycle events in renal epithelial cells.
    [Show full text]
  • The Role of the Rho Gtpases in Neuronal Development
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The role of the Rho GTPases in neuronal development Eve-Ellen Govek,1,2, Sarah E. Newey,1 and Linda Van Aelst1,2,3 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 11724, USA; 2Molecular and Cellular Biology Program, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA Our brain serves as a center for cognitive function and and an inactive GDP-bound state. Their activity is de- neurons within the brain relay and store information termined by the ratio of GTP to GDP in the cell and can about our surroundings and experiences. Modulation of be influenced by a number of different regulatory mol- this complex neuronal circuitry allows us to process that ecules. Guanine nucleotide exchange factors (GEFs) ac- information and respond appropriately. Proper develop- tivate GTPases by enhancing the exchange of bound ment of neurons is therefore vital to the mental health of GDP for GTP (Schmidt and Hall 2002); GTPase activat- an individual, and perturbations in their signaling or ing proteins (GAPs) act as negative regulators of GTPases morphology are likely to result in cognitive impairment. by enhancing the intrinsic rate of GTP hydrolysis of a The development of a neuron requires a series of steps GTPase (Bernards 2003; Bernards and Settleman 2004); that begins with migration from its birth place and ini- and guanine nucleotide dissociation inhibitors (GDIs) tiation of process outgrowth, and ultimately leads to dif- prevent exchange of GDP for GTP and also inhibit the ferentiation and the formation of connections that allow intrinsic GTPase activity of GTP-bound GTPases (Zalc- it to communicate with appropriate targets.
    [Show full text]
  • Evaluating the Therapeutic Potential of the Pak1 and Tbk1 Kinases in Pancreatic Ductal Adenocarcinoma
    EVALUATING THE THERAPEUTIC POTENTIAL OF THE PAK1 AND TBK1 KINASES IN PANCREATIC DUCTAL ADENOCARCINOMA Nicole Marie Baker A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Pharmacology Chapel Hill 2016 Approved by: Channing J. Der Adrienne D. Cox Lee M. Graves Gary L. Johnson M. Ben Major © 2016 Nicole Marie Baker ALL RIGHTS RESERVED ii ABSTRACT Nicole Marie Baker: Evaluating the therapeutic potential of the PAK1 and TBK1 kinases in pancreatic ductal adenocarcinoma (Under the direction of Channing J. Der) Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal cancer characterized by a high frequency (>95%) of activating mutations in the KRAS oncogene, which is a well-validated driver of PDAC growth. However, to date, no successful anti-KRAS therapies have been developed. Inhibitors targeting components of KRAS downstream signaling pathways, when used as monotherapy or in combination, have been ineffective for long-term treatment of KRAS -mutant cancers. Decidedly, the most studied and most targeted KRAS effector pathways have been the RAF-MEK-ERK mitogen-activated protein kinase (MAPK) cascade and the PI3K-AKT-mTOR lipid kinase pathway. The apparent lack of success exhibited by inhibitors of these pathways is due, in part, to an underestimation of the importance of other effectors in KRAS-dependent cancer growth. Additionally, compensatory mechanisms reprogram these signaling networks to overcome the action of inhibitors of the ERK MAPK and PI3K pathways. Consequently, the central hypothesis of my dissertation research is that a better understanding of the role of less studied KRAS effector signaling pathways may lead to more effective therapeutic strategies to block KRAS effector signaling and PDAC growth.
    [Show full text]
  • Rho Gtpases of the Rhobtb Subfamily and Tumorigenesis1
    Acta Pharmacol Sin 2008 Mar; 29 (3): 285–295 Invited review Rho GTPases of the RhoBTB subfamily and tumorigenesis1 Jessica BERTHOLD2, Kristína SCHENKOVÁ2, Francisco RIVERO2,3,4 2Centers for Biochemistry and Molecular Medicine, University of Cologne, Cologne, Germany; 3The Hull York Medical School, University of Hull, Hull HU6 7RX, UK Key words Abstract Rho guanosine triphosphatase; RhoBTB; RhoBTB proteins constitute a subfamily of atypical members within the Rho fa- DBC2; cullin; neoplasm mily of small guanosine triphosphatases (GTPases). Their most salient feature 1This work was supported by grants from the is their domain architecture: a GTPase domain (in most cases, non-functional) Center for Molecular Medicine Cologne, the is followed by a proline-rich region, a tandem of 2 broad-complex, tramtrack, Deutsche Forschungsgemeinschaft, and the bric à brac (BTB) domains, and a conserved C-terminal region. In humans, Köln Fortune Program of the Medical Faculty, University of Cologne. the RhoBTB subfamily consists of 3 isoforms: RhoBTB1, RhoBTB2, and RhoBTB3. Orthologs are present in several other eukaryotes, such as Drosophi- 4 Correspondence to Dr Francisco RIVERO. la and Dictyostelium, but have been lost in plants and fungi. Interest in RhoBTB Phn 49-221-478-6987. Fax 49-221-478-6979. arose when RHOBTB2 was identified as the gene homozygously deleted in E-mail [email protected] breast cancer samples and was proposed as a candidate tumor suppressor gene, a property that has been extended to RHOBTB1. The functions of RhoBTB pro- Received 2007-11-17 Accepted 2007-12-16 teins have not been defined yet, but may be related to the roles of BTB domains in the recruitment of cullin3, a component of a family of ubiquitin ligases.
    [Show full text]
  • Novel 2,7-Diazaspiro[4,4]Nonane Derivatives to Inhibit Mouse and Human Osteoclast Activities and Prevent Bone Loss in Ovariectom
    Novel 2,7-Diazaspiro[4,4]nonane Derivatives to Inhibit Mouse and Human Osteoclast Activities and Prevent Bone Loss in Ovariectomized Mice without Affecting Bone Formation Lucile Mounier, Anne Morel, Yann Ferrandez, Jukka Morko, Jukka Vääräniemi, Marine Gilardone, Didier Roche, Jacqueline Cherfils, Anne Blangy To cite this version: Lucile Mounier, Anne Morel, Yann Ferrandez, Jukka Morko, Jukka Vääräniemi, et al.. Novel 2,7- Diazaspiro[4,4]nonane Derivatives to Inhibit Mouse and Human Osteoclast Activities and Prevent Bone Loss in Ovariectomized Mice without Affecting Bone Formation. Journal of Medicinal Chemistry, American Chemical Society, 2020, 10.1021/acs.jmedchem.0c01201. hal-03006787 HAL Id: hal-03006787 https://hal.archives-ouvertes.fr/hal-03006787 Submitted on 16 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Novel 2,7-Diazaspiro[4,4]nonane derivatives to inhibit mouse and human osteoclast activities and to prevent bone loss in ovariectomized mice without affecting bone formation. Lucile Mounier†, Anne Morel†, Yann Ferrandez‡, Jukka Morko∥, Jukka Vääräniemi∥, Marine Gilardone⊥, Didier Roche⊥, Jacqueline Cherfils‡, Anne Blangy†,* † Centre de Recherche de Biologie Cellulaire de Montpellier, CRBM, Univ Montpellier, CNRS, 34000 Montpellier, France.
    [Show full text]
  • Differential Expression Profiles of Long Noncoding Rnas and Mrnas In
    Li et al. Stem Cell Research & Therapy (2021) 12:9 https://doi.org/10.1186/s13287-020-02040-8 RESEARCH Open Access Differential expression profiles of long noncoding RNAs and mRNAs in human bone marrow mesenchymal stem cells after exposure to a high dosage of dexamethasone Tao Li1†, Yingxing Xu1,2,3†, Yingzhen Wang1 and Yaping Jiang4* Abstract Background: Abnormalities in apoptosis, cell cycle, proliferation, and differentiation of human bone marrow mesenchymal stem cells (hBMSCs) significantly impact bone metabolism and remodeling, resulting in various skeletal disorders. Long-term exposure to a high dosage of dexamethasone (Dex) induces apoptosis and inhibits the proliferation of mesenchymal stromal cells (MSCs), which are probable primary causes of various skeletal disorders. However, to date, the exact mechanisms of action of Dex on hBMSCs have not been fully elucidated. Methods: To explore the effects of Dex on apoptosis, cell cycle, proliferation, senescence, osteogenic and adipogenic differentiation of hBMSCs at the various exposure times and concentrations, Hoechst 33342/PI staining, flow cytometry, crystal violet assay, β-galactosidase (β-GAL) activity assay, alizarin red S (ARS) staining assay, and Oil Red O (ORO) staining assay were performed. A microarray assay was used to identify differentially expressed lncRNAs and mRNAs in 10− 6 mol/L Dex-treated hBMSCs, and a bioinformatics analysis was conducted to further explore the role of these differentially expressed lncRNAs and mRNAs in the coding and noncoding (CNC) network. Furthermore, the microarray results were validated using quantitative real-time PCR (qRT-PCR) analysis. (Continued on next page) * Correspondence: [email protected] †Tao Li and Yingxing Xu contributed equally to this work.
    [Show full text]
  • Directed Differentiation of Human Embryonic Stem Cells Into Haematopoietic and Definitive Endodermal Lineages
    DIRECTED DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO HAEMATOPOIETIC AND DEFINITIVE ENDODERMAL LINEAGES ABRAHAM SUMAN MARY (M.Sc MICROBIOLOGY, UNIV. OF MUMBAI, INDIA) A THESIS SUBMITTED FOR THE DEGREE OF MASTER OF SCIENCE DEPARTMENT OF BIOCHEMISTRY NATIONAL UNIVERSITY OF SINGAPORE 2009 ACKNOWLEDGEMENTS In all things I give YOU glory! You have always led me through amazing paths and given me gifts that I don’t deserve. I thank you Lord for all the blessings you constantly shower on me. Everything is possible with God! I thank Dr. Alan Colman for being my guide and helping me to initiate the work contained in this dissertation. His support and encouragement have been invaluable. Thank you, Alan for your support through the years. Dr. Norris Ray Dunn took me under his wing and guided me through this endeavour. He has been a true mentor, always willing to teach, and I have learned a lot from him. Ray, thank you for showing me the way and helping me reach this juncture. A significant part of the research was conducted at ES Cell International Pte Ltd to whom I would like to express my sincere gratitude. Triona, Jacqui, Robert, Michael, Bruce, Chirag, Suzan and so many others have played important roles and encouraged me at all times. Critical portions of this work were done at the Institute of Medical Biology, A*Star. I would like to register my appreciation for the support and help provided by many people in IMB especially, members of the Ray Dunn lab, Mike Jones lab and Alan Colman lab. Kee Yew, thank you for giving me your precious time and helping me with some of the most important data in this dissertation.
    [Show full text]
  • The Roles of Small Gtpases in Osteoclast Biology Megan M
    yst ar S em ul : C c u s r u r e M n Weivoda and Oursler, Orthopedic Muscul Syst t & R Orthopedic & Muscular System: c e i s 2014, 3:3 d e e a p ISSN: 2161-0533r o c h h t r DOI: 10.4172/2161-0533.1000161 O Current Research Review Article Open Access The Roles of Small GTPases in Osteoclast Biology Megan M. Weivoda* and Merry Jo Oursler Endocrine Research Unit, Mayo Clinic, USA *Corresponding author: Megan M. Weivoda, Endocrine Research Unit, Mayo Clinic, 200 First Street NW, Rochester, MN 55905, USA, Tel: 507-293-3242; E-mail: [email protected] Received date: May 24, 2014, Accepted date: Jul 16, 2014, Published date: Jul 22, 2014 Copyright: © 2014 Weivoda MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract The adult skeleton undergoes bone remodeling that consists of bone formation by osteoblasts and bone resorption by osteoclasts. When the amount of bone resorbed is greater than the amount of new bone formed, low bone mass results, putting individuals at increased risk for osteoporosis and osteoporotic bone fracture. Nitrogenous bisphosphonates (NBPs) are the most common first line treatment for conditions of low bone mass. NBPs reduce osteoclast bone resorption by impairing the post-translational modification of small GTPases. Small GTPases play crucial roles in the differentiation, function, and survival of osteoclasts. Understanding the roles of individual small GTPases in osteoclast biology may lead to more targeted therapies for the treatment of low bone mass.
    [Show full text]
  • Cell Signaling by Rho and Miro Gtpases
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 320 Cell signaling by Rho and Miro GTPases Studies of Rho GTPases in Cytoskeletal Reorganizations and of Miro GTPases in Mitochondrial Dynamics ÅSA FRANSSON ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 UPPSALA ISBN 978-91-554-7122-4 2008 urn:nbn:se:uu:diva-8514 ! " #$ $$% $&'#( ) ! ) ) *! ! ! + , ! - . $$% /! 0 * 1 ) /! 0 * 2 / 3 ) 0 * ! " $ 4 516 &4%7&#7((74#7 ! / ) ) 0 * 8 ! ) ' ! / / / ") /! ) ! 8 ) 0 * ) +! ! + 0 *7 0*7 ! ! + ) ! ) ) ! /! ! /! 0 * ! 3 ) ! 2 ! +! ! 0 * ) ! ! " ) ! ))2 2 /! 0 * "! ! ! /! 0 * $ /! 0 * ! ) ! ! /! " /# +!! ! ) 7 5 )) ! )) ) /! 0 * ! + ) /! 0 * ! 9*",: ! )) ! 3 ) ! 2 ; ) ) ) ! )) ) ! /! 0 * + ! ! + )) ) /! 0 * ! ) ! ! ! 5 ) /72 0 * + ) ! 0 * 9 ! /! : 5 !3 ) + ! ! ! ) ! ! ) ! ) ! ! " + ! ) !+ ! !! ! ! ! ) ! +! 5 ) ! ) ! ) /! 0 * / ) /! 0 * 2 0 * ! ! " # $ %&% '()%*+, < . - $$% 5116 #=(#7=$= 516 &4%7&#7((74#7 ' ''' 7%(# 9! '>> 2> ? @ ' ''' 7%(#: Till mina nära och kära The big wheel keeps on turning On a simple line day by day The earth spins on its axis One man struggles while another relaxes (Massive Attack, Hymn
    [Show full text]
  • STAT3-Mediated Metabolic Switch Is Involved in Tumour Transformation and STAT3 Addiction
    University of Central Florida STARS Faculty Bibliography 2010s Faculty Bibliography 1-1-2010 STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction Marco Demaria Carlotta Giorgi Magdalena Lebiedzinska Giovanna Esposito Luca D'Angeli See next page for additional authors Find similar works at: https://stars.library.ucf.edu/facultybib2010 University of Central Florida Libraries http://library.ucf.edu This Article is brought to you for free and open access by the Faculty Bibliography at STARS. It has been accepted for inclusion in Faculty Bibliography 2010s by an authorized administrator of STARS. For more information, please contact [email protected]. Recommended Citation Demaria, Marco; Giorgi, Carlotta; Lebiedzinska, Magdalena; Esposito, Giovanna; D'Angeli, Luca; Bartoli, Antonietta; Gough, Daniel J.; Turkson, James; Levy, David E.; Watson, Christine J.; Wieckowski, Mariusz R.; Provero, Paolo; Pinton, Paolo; and Poli, Valeria, "STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction" (2010). Faculty Bibliography 2010s. 106. https://stars.library.ucf.edu/facultybib2010/106 Authors Marco Demaria, Carlotta Giorgi, Magdalena Lebiedzinska, Giovanna Esposito, Luca D'Angeli, Antonietta Bartoli, Daniel J. Gough, James Turkson, David E. Levy, Christine J. Watson, Mariusz R. Wieckowski, Paolo Provero, Paolo Pinton, and Valeria Poli This article is available at STARS: https://stars.library.ucf.edu/facultybib2010/106 www.impactaging.com AGING, November 2010, Vol 2 N 11 Research Paper A STAT3‐mediated metabolic switch is involved in tumour transformation and STAT3 addiction Marco Demaria1, Carlotta Giorgi2, Magdalena Lebiedzinska 3, Giovanna Esposito4, Luca 4 4 5 6 5 D'Angeli , Antonietta Bartoli , Daniel J. Gough , James Turkson , David E.
    [Show full text]
  • The RHO Family Gtpases: Mechanisms of Regulation and Signaling
    cells Review The RHO Family GTPases: Mechanisms of Regulation and Signaling Niloufar Mosaddeghzadeh and Mohammad Reza Ahmadian * Institute of Biochemistry and Molecular Biology II, Medical Faculty of the Heinrich Heine University, Universitätsstrasse 1, Building 22.03.05, 40225 Düsseldorf, Germany; [email protected] * Correspondence: [email protected] Abstract: Much progress has been made toward deciphering RHO GTPase functions, and many studies have convincingly demonstrated that altered signal transduction through RHO GTPases is a recurring theme in the progression of human malignancies. It seems that 20 canonical RHO GTPases are likely regulated by three GDIs, 85 GEFs, and 66 GAPs, and eventually interact with >70 downstream effectors. A recurring theme is the challenge in understanding the molecular determinants of the specificity of these four classes of interacting proteins that, irrespective of their functions, bind to common sites on the surface of RHO GTPases. Identified and structurally verified hotspots as functional determinants specific to RHO GTPase regulation by GDIs, GEFs, and GAPs as well as signaling through effectors are presented, and challenges and future perspectives are discussed. Keywords: CDC42; effectors; RAC1; RHOA; RHOGAP; RHOGDI; RHOGEF; RHO signaling 1. Introduction Citation: Mosaddeghzadeh, N.; The RHO (RAS homolog) family is an integral part of the RAS superfamily of guanine Ahmadian, M.R. The RHO Family nucleotide-binding proteins. RHO family proteins are crucial for several reasons: (i) ap- GTPases: Mechanisms of Regulation proximately 1% of the human genome encodes proteins that either regulate or are regulated and Signaling. Cells 2021, 10, 1831. by direct interaction with RHO proteins; (ii) they control almost all fundamental cellular https://doi.org/10.3390/cells10071831 processes in eukaryotes including morphogenesis, polarity, movement, cell division, gene expression, and cytoskeleton reorganization [1]; and (iii) they are associated with a series Academic Editor: Bor Luen Tang of human diseases (Figure1)[2].
    [Show full text]